{"organizations": [], "uuid": "892472aad9b8382d8a93b93d50c7dbb97aa699b0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/samsung-bioepis-stocks-samsung-ct-corp/samsung-ct-shares-rise-after-report-of-planned-stake-purchase-in-biopharma-affiliate-idUSS6N1R202X", "country": "US", "domain_rank": 408, "title": "Samsung C&T shares rise after report of planned stake purchase in biopharma affiliate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T08:16:00.000+03:00", "replies_count": 0, "uuid": "892472aad9b8382d8a93b93d50c7dbb97aa699b0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/samsung-bioepis-stocks-samsung-ct-corp/samsung-ct-shares-rise-after-report-of-planned-stake-purchase-in-biopharma-affiliate-idUSS6N1R202X", "ord_in_thread": 0, "title": "Samsung C&T shares rise after report of planned stake purchase in biopharma affiliate", "locations": [], "entities": {"persons": [{"name": "stephen coates", "sentiment": "none"}, {"name": "joyce lee", "sentiment": "none"}], "locations": [{"name": "seoul", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "samsung c&t corp", "sentiment": "negative"}, {"name": "samsung c&t", "sentiment": "negative"}, {"name": "samsung bioepis co ltd", "sentiment": "none"}, {"name": "samsung biologics co ltd", "sentiment": "none"}, {"name": "samsung", "sentiment": "none"}, {"name": "samsung bioepis", "sentiment": "none"}, {"name": "mbc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SEOUL, April 10 (Reuters) - Shares in Samsung C&T Corp rose 3.6 percent on Tuesday after a report said the company is considering raising up to 3 trillion won ($2.8 billion) to buy a 30 percent stake in biopharma affiliate Samsung Bioepis Co Ltd.\nSamsung C&T has been contacting large financial institutions to raise the money, South Korean TV channel MBC reported on Monday, citing an unnamed person with knowledge of Samsungâ€™s process.\nAnother affiliate, Samsung BioLogics Co Ltd, which owned 94.6 percent of Samsung Bioepis as of end-2017, saw its shares rise 6.8 percent in early trade. ($1 = 1,068.8600 won) (Reporting by Joyce Lee; Editing by Stephen Coates)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-10T08:16:00.000+03:00", "crawled": "2018-04-10T13:02:14.064+03:00", "highlightTitle": ""}